What were Sastasundar Ventures Ltd's latest quarterly results?
Sastasundar Ventures Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +101.0%
- Revenue Growth YoY: +22.9%
- Operating Margin: -3.0%
Sastasundar Ventures Ltd (Pharmacy Distribution) — fundamental analysis, earnings data, and key metrics. PE: 33.7. ROE: 4.6%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Sastasundar Ventures Ltd's latest quarterly results (Dec 2025) show
Sastasundar Ventures Ltd's current PE ratio is 33.7x.
Sastasundar Ventures Ltd's price-to-book ratio is 1.3x.
Sastasundar Ventures Ltd's fundamental strength based on key financial ratios
Sastasundar Ventures Ltd has a debt-to-equity ratio of N/A.
Sastasundar Ventures Ltd's return ratios over recent years
Sastasundar Ventures Ltd's operating cash flow is negative (FY2025).
Sastasundar Ventures Ltd currently does not pay a significant dividend (yield 0.00%).
Sastasundar Ventures Ltd's shareholding pattern (Dec 2025)
Sastasundar Ventures Ltd's promoter holding has increased recently.
Sastasundar Ventures Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Sastasundar Ventures Ltd may be worth studying
Sastasundar Ventures Ltd investment thesis summary:
Sastasundar Ventures Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.